| All participants | Q1 (< 7.96) | Q2 (7.96–8.57) | Q3 (> 8.57) | p value |
---|---|---|---|---|---|
Participants (n) | 912 | 304 | 304 | 304 | Â |
TyG index | 8.3 ± 0.7 | 7.6 ± 0.3 | 8.3 ± 0.2 | 9.0 ± 0.4 |  < 0.001*** |
Sex (n%) |  |  |  |  |  < 0.001*** |
 Males | 592 (64.9) | 128 (42.1) | 203 (66.8) | 261 (85.9) |  |
 Females | 320 (35.1) | 176 (57.9) | 101 (33.2) | 43 (14.1) |  |
Age (years) | 51.1 ± 9.6 | 50.7 ± 10.1 | 51.6 ± 9.4 | 51.1 ± 9.2 | 0.493 |
BMI (kg/m2) | 23.1 ± 3.1 | 21.8 ± 2.5 | 23.1 ± 3.3 | 24.5 ± 3.0 |  < 0.001*** |
SBP (mmHg) | 120.2 ± 15.0 | 114.7 ± 13.9 | 120.9 ± 15.4 | 125.1 ± 13.7 |  < 0.001*** |
DBP (mmHg) | 76.1 ± 10.0 | 72.0 ± 9.4 | 76.4 ± 10.2 | 80.0 ± 8.7 |  < 0.001*** |
FBG (mg/dL) | 98.1 ± 14.1 | 92.2 ± 7.6 | 98.0 ± 10.4 | 104.0 ± 18.9 |  < 0.001*** |
Uric acid (mg/dL) | 5.3 ± 1.4 | 4.6 ± 1.3 | 5.2 ± 1.3 | 6.0 ± 1.3 |  < 0.001*** |
AST (IU/L) | 19.0 (16.0, 23.0) | 19.0 (16.0, 22.0) | 19.0 (16.0, 23.0) | 21.0 (17.0, 26.0) |  < 0.001*** |
ALT (IU/L) | 19.0 (14.0, 26.0) | 16.0 (12.8, 20.0) | 18.0 (14.0, 23.2) | 23.0 (18.0, 34.0) |  < 0.001*** |
γGTP (IU/L) | 19.0 (14.0, 28.0) | 14.0 (11.0, 19.0) | 18.5 (14.0, 26.0) | 25.0 (18.0, 43.0) |  < 0.001*** |
TC (mg/dL) | 209.8 ± 35.9 | 198.4 ± 33.9 | 208.0 ± 33.7 | 223.1 ± 35.8 |  < 0.001*** |
TG (mg/dL) | 99.9 ± 74.9 | 44.2 ± 12.3 | 81.8 ± 14.8 | 173.6 ± 87.3 |  < 0.001*** |
HDL-C (mg/dL) | 53.5 ± 14.6 | 62.0 ± 14.0 | 53.4 ± 13.1 | 45.2 ± 11.4 |  < 0.001*** |
LDL-C (mg/dL) | 128.1 ± 31.7 | 116.6 ± 29.2 | 130.4 ± 28.7 | 137.1 ± 33.5 |  < 0.001*** |
eGFR (mL/min/1.73 m2) | 70.4 ± 12.0 | 73.5 ± 13.0 | 70.2 ± 11.4 | 67.6 ± 11.0 |  < 0.001*** |
Current smoker (n%) |  |  |  |  |  < 0.001*** |
 None or past | 715 (78.4) | 263 (86.5) | 233 (76.6) | 219 (72) |  |
 Current | 197 (21.6) | 41 (13.5) | 71 (23.4) | 85 (28) |  |
Alcohol group (n%) |  |  |  |  |  < 0.001*** |
0–40 g/week | 594 (65.1) | 225 (74) | 194 (63.8) | 175 (57.6) |  |
40–140 g/week | 150 (16.4) | 42 (13.8) | 59 (19.4) | 49 (16.1) |  |
140–280 g/week | 88 (9.6) | 23 (7.6) | 33 (10.9) | 32 (10.5) |  |
 > 280 g/week | 80 (8.8) | 14 (4.6) | 18 (5.9) | 48 (15.8) |  |
Regular exercise (n%) | Â | Â | Â | Â | 0.008** |
 < 1/week | 735 (80.6) | 229 (75.3) | 247 (81.2) | 259 (85.2) |  |
 ≥ 1/week | 177 (19.4) | 75 (24.7) | 57 (18.8) | 45 (14.8) |  |
Fatty liver (n%) |  |  |  |  |  < 0.001*** |
None | 647 (70.9) | 274 (90.1) | 229 (75.3) | 144 (47.4) | Â |
Moderate or severe | 265 (29.1) | 30 (9.9) | 75 (24.7) | 160 (52.6) | Â |
Menopausal state (n%) | Â | Â | Â | Â | 0.071 |
Menopausal | 138 (43.1) | 86 (48.9) | 36 (35.6) | 16 (37.2) | Â |
Postmenopausal | 182 (56.9) | 90 (51.1) | 65 (64.4) | 27 (62.8) | Â |
ABI | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.2 ± 0.1 | 0.001** |
baPWV(cm/s) | 1415.8 ± 246.3 | 1350.7 ± 226.1 | 1424.5 ± 234.6 | 1472.1 ± 262.0 |  < 0.001*** |